Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease

被引：0
|
作者：
Hassan Saadati
Hamid Reza Baradaran
Goodarz Danaei
Afshin Ostovar
Farzad Hadaegh
Leila Janani
Ewout W. Steyerberg
Davood Khalili
机构：
[1] Iran University of Medical Sciences,Department of Epidemiology, School of Public Health
[2] Medical Sciences and Nutrition University of Aberdeen,Ageing Clinical and Experimental Research Team, Institute of Applied Health Sciences, School of Medicine
[3] Iran University of Medical Sciences,Endocrine Research Center, Institute of Endocrinology and Metabolism
[4] Harvard TH Chan School of Public Health,Department of Global Health and Population and Department of Epidemiology
[5] Tehran University of Medical Sciences,Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute
[6] Research Institute for Endocrine Sciences,Prevention of Metabolic Disorders Research Center
[7] Shahid Beheshti University of Medical Sciences,Department of Biostatistics, School of Public Health
[8] Iran University of Medical Sciences,Department of Biomedical Data Sciences
[9] Leiden University Medical Center,Department of Public Health
[10] Erasmus MC,Department of Biostatistics and Epidemiology
[11] Research Institute for Endocrine Sciences,undefined
[12] Shahid Beheshti University of Medical Sciences,undefined
来源：
BMC Medical Informatics and Decision Making | / 20卷
关键词：
Preferences; Statins; Benefit harm outcomes; Primary prevention; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Barriers and facilitators to cardiovascular disease prevention following hypertensive disorders of pregnancy in primary health care
    Slater, Kaylee
    Taylor, Rachael
    Collins, Clare
    McLaughlin, Karen
    Pennell, Craig
    Hutchesson, Melinda
    AUSTRALIAN JOURNAL OF PRIMARY HEALTH, 2022, 28 (04) : LV - LV
  • [42] Primary Care Providers' Awareness of Physical Activity-Related Intensive Behavioral Counseling Services for Cardiovascular Disease Prevention
    Omura, John D.
    Watson, Kathleen B.
    Loustalot, Fleetwood
    Fulton, Janet E.
    Carlson, Susan A.
    AMERICAN JOURNAL OF HEALTH PROMOTION, 2019, 33 (02) : 208 - 216
  • [43] A predictive model of the health benefits and cost effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patients
    Milne, RJ
    VanderHoorn, S
    Jackson, RT
    PHARMACOECONOMICS, 1997, 12 (03) : 384 - 408
  • [44] A Predictive Model of the Health Benefits and Cost Effectiveness of Celiprolol and Atenolol in Primary Prevention of Cardiovascular Disease in Hypertensive Patients
    Richard J. Milne
    Stephen Vander Hoorn
    Rodney T. Jackson
    PharmacoEconomics, 1997, 12 : 384 - 408
  • [45] Atherosclerotic Cardiovascular Disease in Psoriatic Arthritis: Evaluation of Risk Factor Management and Use of Aspirin and Statin for Prevention in a Primary Care Setting
    Linh Truong
    Ridolfi, Nicole
    Wong, Maida
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [46] Results of a Markov Model Analysis to Assess the Cost-Effectiveness of Statin Therapy for the Primary Prevention of Cardiovascular Disease in Korea: The Korean Individual-Microsimulation Model for Cardiovascular Health Interventions
    Kang, Hye-Young
    Ko, Su-Kyoung
    Liew, Danny
    CLINICAL THERAPEUTICS, 2009, 31 (12) : 2919 - 2930
  • [47] Optimizing statin therapy for primary prevention of cardiovascular disease in type 2 diabetes mellitus patients: Exploring dose, class, and intensity
    Yu, Jung-Min
    Chen, Wan-Ming
    Shia, Ben-Chang
    Wu, Szu-Yuan
    DIABETES & VASCULAR DISEASE RESEARCH, 2023, 20 (06):
  • [48] Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts
    Yebyo, Henock G.
    Aschmann, Helene E.
    Yu, Tsung
    Puhan, Milo A.
    BMC CARDIOVASCULAR DISORDERS, 2018, 18
  • [49] Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts
    Henock G. Yebyo
    Hélène E. Aschmann
    Tsung Yu
    Milo A. Puhan
    BMC Cardiovascular Disorders, 18
  • [50] Effectiveness of multifactorial interventions in primary health care settings for primary prevention of cardiovascular disease: A systematic review of systematic reviews
    Alvarez-Bueno, Celia
    Cavero-Redondo, Ivan
    Martinez-Andres, Maria
    Arias-Palencia, Natalia
    Ramos-Blanes, Rafael
    Salcedo-Aguilar, Fernando
    PREVENTIVE MEDICINE, 2015, 76 : S68 - S75
12345